共 50 条
[1]
Woodward DF(2001)The pharmacology of bimatoprost (Lumigan) Surv Ophthalmol 45 S337-S345
[2]
Krauss AH(2003)Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther 305 772-785
[3]
Chen J(2005)First-choice treatment preferences for primary open-angle glaucoma in the United Kingdom Eye (Lond) 19 923-924
[4]
Woodward DF(2007)The side effects of the prostaglandin analogues Expert Opin Drug Saf 6 45-52
[5]
Krauss AH(2009)Prostaglandin analogues in the anterior eye: their pressure lowering action and side effects Exp Eye Res 88 786-791
[6]
Chen J(2003)Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension Adv Ther 20 1-13
[7]
McKee HD(2004)Conjunctival hyperemia associated with bimatoprost use: a histopathologic study Am J Ophthalmol 138 310-313
[8]
Gupta MS(2001)Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization J Glaucoma 10 483-486
[9]
Ahad MA(2002)Ocular tolerance of preservatives and alternatives Eur J Pharm Biopharm 53 263-280
[10]
Saldaña M(2006)Are multidose over-the-counter artificial tears adequately preserved? Cornea 25 432-437